Nyu Langone Health
Clinical trials sponsored by Nyu Langone Health, explained in plain language.
-
Blood test may help doctors decide when to add a third drug for melanoma
Disease control Recruiting nowThis study tests whether a blood test that measures tumor DNA (ctDNA) can help doctors decide when to add a third immunotherapy drug (ipilimumab) for people with advanced melanoma who are already taking two others (nivolumab and relatlimab). About 90 adults with advanced or metas…
Phase: PHASE4 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
New combo drug therapy aims to protect hearts after noncardiac surgery
Disease control Recruiting nowThis study tests whether giving a blood thinner (rivaroxaban) and a cholesterol-lowering drug (atorvastatin) can reduce heart-related risks in adults who had a heart injury after noncardiac surgery. The study includes 50 people aged 45 or older who recently had major surgery and …
Phase: EARLY_PHASE1 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Apr 22, 2026 16:00 UTC
-
At-Home brain zaps tested to restore failing eyesight
Disease control Recruiting nowThis study is testing whether a home-based treatment using gentle electrical stimulation around the eye can help improve vision in people with optic nerve damage. Researchers will enroll 70 adults with optic neuropathy to use the device every other day for 8 weeks. The goal is to…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Apr 21, 2026 12:44 UTC
-
New hope for Tough-to-Treat lung cancer: trial targets specific genetic flaw
Disease control Recruiting nowThis study is testing an experimental drug called DRP-104 for people with advanced non-small cell lung cancer that has specific genetic changes (NFE2L2 or KEAP1) and has stopped responding to standard chemotherapy and immunotherapy. The main goal is to see if the drug can shrink …
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Apr 20, 2026 16:18 UTC
-
Brain scans may predict who benefits from pancreatitis procedure
Knowledge-focused Recruiting nowThis study looks at whether brain activity and pain sensitivity tests can predict how well someone with chronic pancreatitis will respond to endoscopic therapy. About 100 adults scheduled for the procedure will have EEGs, sensory tests, and questionnaires before treatment. Their …
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC
-
Swallow this pill to map your gut bugs!
Knowledge-focused Recruiting nowThis study is testing a new 3D-printed pill that people swallow to collect bacteria samples from the gut, including the small intestine. Ten healthy adults aged 18-65 will take the pill and provide stool samples for comparison. The goal is to see if the pill is safe and can accur…
Phase: NA • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Apr 24, 2026 16:07 UTC
-
Diabetes study probes Cholesterol's hidden effects on blood
Knowledge-focused Recruiting nowThis study looks at how reducing cholesterol changes blood cell activity and blood vessel function in 125 people with type 1 diabetes. Participants will have their cholesterol lowered and be monitored for one to two months. The goal is to learn more about heart disease risks in d…
Phase: PHASE4 • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Apr 24, 2026 16:05 UTC
-
Scientists probe how worry warps our choices
Knowledge-focused Recruiting nowThis study aims to understand how stress and anxiety change the way people learn and make decisions. Researchers will recruit 200 adults, including some with anxiety disorders, to complete computer tasks and surveys. The goal is to gather knowledge about brain processes, not to t…
Phase: NA • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Apr 22, 2026 15:58 UTC